WallStreetZenWallStreetZen

NASDAQ: GDTC
Cytomed Therapeutics Ltd Earnings Dates, Reports, Calls

OverviewEarnings
RevenueDividendOwnership
Cytomed Therapeutics earnings were -$2.9M for the trailing 12 months ending Jun 30, 2025, with N/A growth year over year. The latest GDTC earnings report on Jun 30, 2025 announced Q2 2025 earnings of N/A, down N/A from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, GDTC reported annual earnings of -$1.9M, with -40.9% growth. The next GDTC earnings date is Nov 14, 2025.

GDTC earnings history

Current Revenue
$176.1k
Current Earnings
-$2.9M
Current Profit Margin
-1,629.2%

GDTC Return on Equity

Current Company
-42.4%
Current Industry
-10.1%
Current Market
30.7%
GDTC's Return on Equity (-42.4%)... subscribe to Premium to read more.
High Return on Equity Performance

GDTC undefined

Current Company
-38.1%
Current Industry
-0.2%
GDTC is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when GDTC announces earnings.

GDTC undefined

Current Company
-47.7%
Current Industry
6.4%
GDTC has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

GDTC vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
GDTC-$2.58M-$2.87MN/A-$0.25
LPTX-$64.86M-$65.69MN/A-$1.58
ENLV-$14.99M-$13.10MN/A-$0.58
CLGN-$12.54M-$13.00MN/A-$1.13
KAPA-$4.70M-$4.71MN/A-$0.34
View Top Biotech Stocks

GDTC earnings dates

Next earnings date
Nov 14, 2025

Cytomed Therapeutics Earnings Reports & History FAQ

What were Cytomed Therapeutics's earnings last quarter?

On GDTC's earnings call on Invalid Date, Cytomed Therapeutics (NASDAQ: GDTC) reported Q2 2025 earnings per share (EPS) of N/A, up N/A year over year. Total GDTC earnings for the quarter were N/A. In the same quarter last year, Cytomed Therapeutics's earnings per share (EPS) was N/A.

If you're new to stock investing, here's how to buy Cytomed Therapeutics stock.

When does Cytomed Therapeutics report earnings?

The next GDTC earnings call is Invalid Date. Add GDTC to your watchlist to be reminded of Cytomed Therapeutics's next earnings date.

Is Cytomed Therapeutics profitable or losing money?

As of the last Cytomed Therapeutics earnings report, Cytomed Therapeutics is currently losing money. Cytomed Therapeutics's net profit (also called net income) for the twelve months ending Jun 30, 2025 was -$2.87 million, a 27.37% increase year over year.

What was GDTC's earnings growth in the past year?

As of Cytomed Therapeutics's earnings date in Invalid Date, Cytomed Therapeutics's earnings has grown year over year. GDTC earnings in the past year totalled -$2.87 million.

What are Cytomed Therapeutics's earnings expectations?

The current EPS estimate for Cytomed Therapeutics's earnings report in Invalid Date is -$0.04.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.